The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I don't know where you source that information, but Dubai 2020 Expo and Tokyo Olympics 2020 WILL be held this year, according to their boards. These are much bigger scale events HYVE can only dream of, and they are being done. Moreover, HYVE has organised shows DURING the Pandemic in many different regions around the globe, I highly doubt they will stop now.
With a claim like this, either show your sources (better not be the Guardian or smth) or risk being perceived as someone who missed their entry point around 70p, before the November Vaccine news spike, thus trying to pull the price down.
340p a year ago. (Before acquiring shoptalk, groceryshop and the virtual thingy).
Hyve is purely an organizer, they don't hold venues or any asset that chews up cash as a maintenance. I assume that overheads (mainly salaries) and minimal marketing spending (%20 of what it was when the shows were running) should be the only real cost here.
In fact, they must have had so much more cash than expected after the RI and cost saving measures, that they dished out some millions recently to buy a virtual expo concept. Its like Tinder, but you get connected to socially and virtually inept business people instead.
I have a follow-up question.
If my holding is already borrowed for shorting, what happens to the sort position / short broker when I put a sell order?
Ghia - Thanks for reaching out. You are right about the timescale. It seems I might have succumbed to fear, thinking there might be a dynamic I have missed while analysing the company, when in fact, my expectations needed a reality check.
Now looking at it more clearly. I didn't sell for 170 not knowing if the technology actually worked or not, so I certainly will not sell at 160 knowing it truly works.
Ok people. I clearly don't know enough about the dynamics of biotech as I think I did a week ago.
Why is the share price drifting down? Do we need a Pfizer to our Biontech or an Astrazeneca to our Oxford before this rises? I thought this was a brakethrough.
Risking entering the conspiracy theory zone here, could this be because the medicine (nasal mcab) is a direct competition to the trillion dollars vaccine industry, and big pharma suppressing the sp. And the news spreading?
It can't be a coincidence that a news article was published on The Guardian yesterday, the day of the RNS, trash talking mcab medicines, regeneron etc saying they aren't effective...
I know this is gold but there is a war here, some unnatural factor messing with the natural balance of supply and demand of the market. This is the only explanation, as 20 out of 20 people I told about TILS have invested in it even though I told them biotech is super risky and all...
I am damn confused, but I will hold, might even add up some...
Congratulations all. Thanks for the mature info sharing people... I have been following this BB for some time now and I noticed a difference today:
NO ONE TALKS ABOUT ACCUSTEM!!!
Another company I am invested just announced positive clinical trials for COVID -19 medicine in the form of a nose spray! So now we not only have vaccines going, but we will have a cure as well! This is surely good news for HYVE, events business, tourism and travel.
Much like the vaccine news rise on November, maybe we can see a cure rise soon?
GLA
https://www.londonstockexchange.com/news-article/TILS/positive-data-nasal-administration-of-foralumab/14848872
I hope the weirdos at Nasdaq doesn't confuse the rise of TLSA for some dodgy Gamestop type of activity, and try to intervene... Oh if you didn't hear, the market over the pond isn't really free anymore.
TLSA IS OVER £180p NOW!
I Assume the Covid-19 news would be timed for the most impact, which is in my opinion, is next week.
The whole world is discussing vaccination now, which started to leave its place to talks about flaws in vaccine supply chains and how countries have failed or succeeded in implementing the vaccination programs. Only after that, will the talk about a cure, rather than a vaccine will be the dominating topic.
Common sense states that's when it needs to hit the RNS about the Brazil Results. People will love the story of "an asthma inhaler that cures covid-19"!!! News outlets will jump on a hot topic to publish it for free, which might even get a retail investor craze going.
Bravo, people! Full of optimism and cost-cutting efficency.
https://hyve.group/CMSPages/GetFile.aspx?guid=dae67569-87f7-46c5-855f-273ba54e9f5d
The Prospectus gave me flashbacks of some past Rights Issues with some other stocks...
How do biotech companies usually raise cash?
Anyways, set final positions by Wednesday closing, Thursday 8.00AM is the day for this bird to fly!
Good week everyone.
I can imagine the jokes on social media and the news regarding TLSA when it rises %30 in a day, people confusing it for TSLA etc. Maybe even a humorous tweet from Elon Musk...
Thanks for the information and the productive criticism everyone. I have a better understanding of the company now, as well as the bulletin board etiquette for aim stocks.
It truly is a huge potential we are sitting on top of here, but one thing I know, biotech is a fickle mistress, driven by anticipation and wishful thinking and humbled by fear and panic.
I, like everyone invested here would like to see the stock soar with good results coming in from recently conducted experiments.
On the other hand, I wonder what actually happens if the results don't satisfy the market as much as it should?
What is the Covid excluded price here? Thanks and good luck all.
I have had this stock on and off for more than 4 years. I had NEVER seen this stock creeping upwards before. It would always slowly creep down and rise fast with good news, only to creep downwards again...
Because people doubled their money in two weeks.
Hyve business as ususal pre covid was 100-120p. After the dilution and Rights Issue the pre covid price would be 300-360p. If the industry recovers fully, thats the price.
Anything under 200 really is a bargain here, though one must contemplate the future of the trade fairs industry. Ill give you a tip, virtual fairs have been around for decades, and If it could, it would have disrupted the industry by now. A disruption should emerge from the industry itself having in depth knowledge of the industry, not from the entreprenaurial minds of software engineers thinking about which industry to disrupt next. Exhibitions are not just b2b commerce, if so alibaba would finish exhibitions long ago.
Exhibitions are handshake, trust, parties, drunk Chinese businesspeople.
Exhibitions are traveling on company budget, meeting new people, a good excuse for the missus when travelling to Moscow.
Exhibitions are where orders are quantified in 40 - foot containers, where some steal their competitions designs, where meetings happen with people that you cant get past the secretary.
Ofcourse, DYOR and all, but trust me when I say this; when covid ends, big name exhibitions will come back stronger than ever, while small, local ones perish...
Hello all. I am very interested in investing on CINE, because I see it as one of the stocks which will increase %300 - 400 through Spring 2021, like HYVE.
The question on my mind is, how much more would this come back before it bounces? Could it survive till March?
Logic tells that when the vaccine comes out December - January, International business travel will commence, exhibitions will take place, tourism will work full capacity again, and cinemas will re-open. All the big movies waiting for covid to end will be rolled out consecutively, cinema will have peak demand, and also factoring in that people have missed going to the movies, attendees count will definitely surge. I can see the celebrity campaigns with #gotothemovies or something cheesy like it, giving messages about supporting the cinema industry etc.
On the other hand, is there an underlying problem with the company itself? I haven't done my homework yet and I know I am being a lazy ass asking this to the db but I have noticed this is an active db and in the past I have had amazing insight from db's.
Thanks
Ok people, the moment of turth for Hyve.
Tomorrow, Intercharm Beauty Show opens in Kiev.
Also Worldfood Moscow opens on 22nd.
The performance indicator we need to look out for is called "Rebook", which basically means if the exhibiting companies renew their contracts for the next year. If there is strong rebook during the show, it means Hyve is on the clear - and we got a stock that is severely undervalued in our hands. If the numbers are low and there is no bookings, we are cursed by the Covid Gods. Unfortunately, the only way to check is if ITE actually decides to tell us, but I have a feeling if the numbers are good, we will see a news article or something... I HOPE.